Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$263,115
+$155,778 QoQ
Shares Held
28,201
+165.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#251
of 640 holders
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Magnetar Financial LLC holds $3,311,353 across 12 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
30,257 | $480,481 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,674 | $450,675 | |
| 3 | LQDA |
Liquidia Corp
|
4,619 | $368,272 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
7,561 | $351,661 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
7,851 | $322,126 | |
| 6 | HLN |
Haleon plc
This page
|
28,201 | $263,115 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
3,009 | $249,084 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
10,906 | $220,083 |
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,115 | 28,201 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $107,337 | 10,617 | Shares | Sole | 2026-02-17 | |
| 2024-09-30 | $1,058,000 | 100,000 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $852,659 | 100,431 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||